Frederic Girard

Frederic Girard is a seasoned professional in the biopharmaceutical industry, currently serving as Senior Director of the BioPharma Business Unit at Bruker BioSpin since November 2024. Prior to this role, Frederic held the position of Senior Scientific Director at Eurofins BioPharma Product Testing from December 2020 to November 2024, where responsibilities included enhancing scientific knowledge and promoting business opportunities. Frederic's extensive experience also includes managing Eurofins Spinnovation Analytical, focusing on analytical R&D and GMP QC testing services as Managing Director, and serving as CEO and co-founder of Spinnovation Biologics. Frederic's academic background includes a Ph.D. in Molecular Biophysics from Université d'Orléans and significant postdoctoral research on the RNA replication system of Hepatitis B virus at both Radboud University and Umeå University.